company background image
EVAN

Evans MedicalNGSE:EVANSMED Stock Report

Market Cap

₦366.2m

7D

0%

1Y

0%

Updated

26 Oct, 2021

Data

Company Financials
EVANSMED fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

EVANSMED Overview

Evans Medical Plc manufactures, markets, and distributes health products.

Price History & Performance

Summary of all time highs, changes and price drops for Evans Medical
Historical stock prices
Current Share Price₦0.50
52 Week High₦0
52 Week Low₦0
Beta0
1 Month Change0%
3 Month Change0%
1 Year Change0%
3 Year Change0%
5 Year Change0%
Change since IPO-51.11%

Recent News & Updates

Shareholder Returns

EVANSMEDNG PharmaceuticalsNG Market
7D0%1.7%1.5%
1Y0%35.1%40.2%

Return vs Industry: EVANSMED underperformed the NG Pharmaceuticals industry which returned 35.1% over the past year.

Return vs Market: EVANSMED underperformed the NG Market which returned 40.2% over the past year.

Price Volatility

Is EVANSMED's price volatile compared to industry and market?
EVANSMED volatility
EVANSMED Beta0
Industry Beta0.56
Market Beta1

Stable Share Price: EVANSMED is less volatile than 75% of NG stocks over the past 3 months, typically moving +/- 0% a week.

Volatility Over Time: EVANSMED's weekly volatility (0%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1954n/an/a

Evans Medical Plc manufactures, markets, and distributes health products. The company operates in the Over the Counter and Prescriptive segments. Its products include anti-malarials, ant-infectives, anti-asthamatics, anti-histaminics, analgesics, anti-ulcerants, anti-hypertensives, anti-diabetics, cold and cough preparations, erectile dysfunctions, energy supplements, herbal products, haematinics blood forming preparations, prostagladins, vitamins and minerals, topical preparations, and pharyngeals.

Evans Medical Fundamentals Summary

How do Evans Medical's earnings and revenue compare to its market cap?
EVANSMED fundamental statistics
Market Cap₦366.17m
Earnings (TTM)-₦964.84m
Revenue (TTM)₦3.34b

0x

P/S Ratio

0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EVANSMED income statement (TTM)
Revenue₦3.34b
Cost of Revenue₦1.96b
Gross Profit₦1.39b
Expenses₦2.35b
Earnings-₦964.84m

Last Reported Earnings

Dec 31, 2014

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did EVANSMED perform over the long term?

See historical performance and comparison

Valuation

Is Evans Medical undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Evans Medical is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Evans Medical has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Future Growth

How is Evans Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.5%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Evans Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Evans Medical performed over the past 5 years?

12.8%

Historical Pharmaceuticals & Biotech annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Evans Medical has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Financial Health

How is Evans Medical's financial position?


In this section we usually analyse Evans Medical's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Evans Medical has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Dividend

What is Evans Medical current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate EVANSMED's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate EVANSMED's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if EVANSMED's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if EVANSMED's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: EVANSMED is not paying a notable dividend for the NG market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of EVANSMED's dividend in 3 years as they are not forecast to pay a notable one for the NG market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.8yrs

Average board tenure


CEO

Evans Medical has no CEO, or we have no data on them.


Board Members

Experienced Board: EVANSMED's board of directors are considered experienced (8.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Evans Medical Plc's employee growth, exchange listings and data sources


Key Information

  • Name: Evans Medical Plc
  • Ticker: EVANSMED
  • Exchange: NGSE
  • Founded: 1954
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₦366.174m
  • Shares outstanding: 732.35m

Number of Employees


Location

  • Evans Medical Plc
  • Plot 6, Abimbola Way
  • Isolo
  • Lagos
  • Nigeria

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/26 15:20
End of Day Share Price2021/10/25 00:00
Earnings2014/12/31
Annual Earnings2014/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.